Press Coverage

The True Costs of Pivotal Trials that Support FDA Approval

Article summarizes a study co-authored by ISMP Senior Scientist Tom Moore and published online in JAMA Internal Medicine that explores the median costs for pivotal clinical trials leading to FDA approval for novel drugs.

For the full text of the article, visit Medscape online


More News

An international medication safety call to action is aimed at preventing fatalities due to medication errors with concentrated potassium injection, inadvertent intraspinal injection of vincristine, and accidental daily instead of weekly dosing of methotrexate in patients with psoriasis or rheumatoid arthritis.